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abstract
Acute Liver Failure is a medical emergency characterised 
by cerebral oedema and non-convulsive seizures. Patients 
with fulminant hepatic failure need urgent workup for liver 
transplantation. In the meantime, a multimodal approach must 
be adopted to decrease the incidence of death from neurological 
complications. 
IntroductIon
Acute liver failure is a rare, life-threatening condition. 
Often it occurs in young, previously healthy individuals. 
Management of these patients is extremely challenging. 
In view of the fact that experience in management outside 
specialised centres is limited, consideration for transfer 
to a tertiary centre with a facility for liver transplantation 
should be taken as early as possible. Management 
guidelines facilitate the standardisation of critical 
care management of these patients amongst different 
specialities, thereby promoting a smoother and more 
efficient continuity of care. 
classIfIcatIon of acute lIver faIlure
Liver failure is a triad of jaundice, coagulopathy and 
encephalopathy.  
The O’Grady System classifies acute liver failure as: 
1. Hyperacute: encephalopathy occurs within 7 days of the 
onset of jaundice; 
2.  Acute: encephalopathy occurs within 8 to 28 days of the 
onset of jaundice; 
3. Subacute: encephalopathy occurs between 29 days to 12 
weeks of the onset of jaundice.  
presentatIon
Acute liver failure presents with acute, severe hepatitis, followed 
by coagulopathy (high INR) and encephalopathy. These patients 
typically lack the clinical and radiological signs associated with 
chronic liver disease, namely hepatomegaly, ascites, clubbing, 
leukonychia, caput medusa, spider naevi, gynaecomastia and 
cirrhosis. Paracetamol overdose is the commonest cause of 
fulminant hepatic failure in developed countries, whereas viral 
hepatitis is the commonest cause worldwide. The development 
of cerebral edema is the main cause of morbidity and mortality in 
patients with acute liver failure.  
pathophysIoloGy of cerebral oedeMa In acute lIver faIlure
1.  hyperaMMonaeMIa
Ammonia, a normal by-product of protein metabolism, is 
detoxified by the liver to urea. In liver failure, failure of hepatic 
ammonia metabolism leads to hyperammonaemia. In the brain, 
ammonia is converted to glutamine. In acute liver failure, this 
acute rise in intra-cerebral glutamine increases the osmotic 
pressure in astrocytes, leading to cerebral oedema. In chronic 
liver disease, the accumulation of intracerebral glutamine is more 
insidious.  Hence, astrocytes have time to equilibrate to these 
osmolar changes and cerebral oedema does not occur.  
2.  MassIve systeMIc InflaMMatory response
This leads to cerebral vessel vasodilatation and increased vessel 
permeability. This promotes the shift of intravascular fluid to the 
interstitial space, thereby leading to cerebral oedema. In chronic 
liver disease, the systemic inflammatory response is much less 
pronounced.
InvestIGatIons of acute lIver faIlure   
All patients presenting with acute, severe hepatitis of uncertain 
aetiology should undergo screening for viruses, autoimmune 
antibodies and toxins, including serum ethanol and paracetamol 
levels, and have a Doppler ultrasound of their liver. Patients with 
established acute liver failure should have 6 to 8 hourly blood 
tests, namely full blood count, serum electrolytes, renal profile, 
clotting profile, liver enzymes including serum albumin, serum 
ammonia and arterial blood gases. Serum phosphate levels 
should be monitored daily as phosphate is consumed during liver 
regeneration leading to hypophosphataemia. Since these patients 
are susceptible to infections, they should have regular blood, urine 
and sputum cultures.
ManaGeMent of acute lIver faIlure
1.  orthotopIc lIver transplant  
Without liver transplantation, the prognosis is very poor in acute 
liver failure. Hence a hepatologist should be involved immediately, 
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even if the patients do not seem sick enough initially. These 
patients deteriorate very fast and may miss the therapeutic time 
window for surgery. There are no universal, exclusion criteria 
for liver transplantation. However, many specialised centres 
agree that patients who are very unstable (overt septic shock 
with multi-organ failure), have uncontrolled seizures or signs 
of impending brainstem herniation (fixed, dilated pupils or 
posturing movements) or have malignancies outside the liver will 
not benefit from liver transplantation. 
The American Society for Study of Liver Diseases has 
recommended the King’s College Criteria in assessing the need 
for liver transplantation in patients with acute liver failure. 
According to the King’s College Criteria, cases of paracetamol-
induced acute liver failure should be referred for liver 
transplantation if they have: 
1. pH < 7.3; or
2. INR > 6.5, serum creatinine > 300 μmol/L and Grade III/IV 
encephalopathy.
According to the King’s College Criteria, cases of non 
paracetamol-induced acute liver failure should be referred for 
liver transplantation if they have:
1. INR > 6.5; or
2. Any 3 of the following: (a) age < 10 years or > 40 years; (b) 
aetiology - non-A, non-B hepatitis or idiosyncratic drug 
reaction; (c) duration of jaundice before encephalopathy >       
7 days; (d) INR > 3.5; and (e) serum bilirubin > 300 μmol/L.
2.  neuroloGIcal ManaGeMent
The two most common neurological complications associated 
with acute liver failure are brain oedema and non-convulsive 
seizures. Intracranial haemorrhage due to coagulopathy is 
rare, but devastating when it occurs. All patients admitted 
with acute liver failure should have regular (30 minutes to 1 
hourly) neurocharting. New, focal neurological deficits are more 
consistent with intracranial haemorrhage and warrant urgent 
CT brain. Symmetrical neurological deterioration with no 
focal deficits is more consistent with cerebral oedema.  EEG is 
warranted in cases of neurological deterioration which cannot 
be explained by CT brain findings to exclude non-convulsive 
seizures, which would require treatment with intravenous 
anticonvulsants.
Brain oedema manifests clinically as severe confusion, 
somnolence and coma. Hence, all patients exhibiting any of these 
symptoms benefit from protective measures to restore cerebral 
perfusion, namely: 
a. Measures to decrease brain oedema1 including:
i. Hyperosmolar therapy with hypertonic saline 
or mannitol aiming for serum osmolarity of 
310-320mOsm/L;
ii. Renal replacement therapy to lower serum ammonia 
to < 60 μmol/L even in the absence of renal failure, as 
ammonia is cleared by dialysis;
iii. Intubation and hyperventilation, aiming for PaCO2 
(arterial partial pressure of carbon dioxide) of 35mmHg. 
Cerebral blood flow is directly related to PaCO2 up to 
certain limits. Hence, by decreasing PaCO2, cerebral 
reference
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blood flow is reduced. Therefore, patients with clinical 
manifestations of intracranial hypertension benefit from 
intubation and controlled, mechanical ventilation even 
if their Glasgow Coma Scale > 8 and they are still able to 
protect their airway
iv. Hypothermia, aiming for a core temperature of 35°C 
as this leads to cerebral vessel vasoconstriction and 
subsequent reduction of intracranial pressure.
b. Measures to promote cerebral venous drainage, namely 
head of bed elevation 30°, maintaining the head of intubated 
patients in the neutral position and avoiding any constrictive 
ties around the neck to fix the endotracheal tube.
3. cardIovascular support
Patients with acute liver failure typically have high cardiac output 
states and vasoplegia.  Noradrenaline is the vasoconstrictor of 
choice to counteract the vasoplegia.  Restrictive fluid measures 
are usually desired to avoid worsening of cerebral oedema. 
These patients are prone to infections and septic shock as they 
are immunocompromised. Therefore, in case of non-improving 
clinical picture, broad spectrum antibiotics and antifungals should 
be considered early. 
4. ManaGeMent of coaGulopathy
Coagulopathy is not corrected unless INR > 6 as it is a useful 
prognostic marker. Beyond this level, transfusion of fresh 
frozen plasma is indicated due to increased risk of spontaneous 
intracranial bleeding.  
5. MetabolIc hoMeostasIs
Hypoglycaemia is common in acute liver failure as the hepatic 
glycogen stores are depleted. In such cases, hypertonic dextrose 
infusions should be used. 5% dextrose should be avoided as it 
worsens cerebral oedema.
6. n-acetylcysteIne InfusIon
In paracetamol overdose, hepatotoxicity occurs due to depletion 
of the hepatic glutathione stores. N-Acetylcysteine replenishes 
this hepatic glutathione. N-Acetylcysteine is also beneficial 
in non-paracetamol-induced acute liver failure as it has anti-
oxidant properties and improves haemodynamics. In both cases, 
N-Acetylcysteine infusion should be commenced immediately 
and continued until discharge from intensive care or liver 
transplantation is performed. 
conclusIon
A multimodal approach to the management of acute liver failure 
addresses the individual pathophysiological processes that occur in 
this condition. It improves chances of survival in patients awaiting 
liver transplantation and dramatically reduces the risk of death 
from neurological complications.  
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